US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion
Patel N, Mohammad A, Ross J, Ramachandran R. US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion. The BMJ 2024, 384: e076138. PMID: 38383007, DOI: 10.1136/bmj-2023-076138.Peer-Reviewed Original ResearchMeSH KeywordsAdvertisingConfusionDrug ApprovalDrug IndustryDrug PrescriptionsHumansUnited StatesUnited States Food and Drug Administration